OECD Health Policy Studies Pharmaceutical Innovation and Access to Medicines PDF Download

Author: OECD
Publisher: OECD Publishing
ISBN: 9264307397
Category :
Languages : en
Pages : 192

View

Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.

Author: OECD
Publisher: Org. for Economic Cooperation & Development
ISBN: 9789264307384
Category : Drug accessibility
Languages : en
Pages : 0

View

Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.

Author: OECD
Publisher: OECD Publishing
ISBN: 9789264044142
Category :
Languages : en
Pages : 216

View

Book Description
This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264044159
Category :
Languages : en
Pages : 216

View

Book Description
This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264266437
Category :
Languages : en
Pages : 228

View

Book Description
This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264076808
Category :
Languages : en
Pages : 132

View

Book Description
This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testing.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264074236
Category :
Languages : en
Pages : 167

View

Book Description
This report report examines selected policies that may help countries better achieve the goal of improved health system efficiency and thus better value for money.

Author:
Publisher:
ISBN: 9789264355514
Category :
Languages : en
Pages : 210

View

Book Description
This report explores how data and digital technology can help achieve policy objectives and drive positive transformation in the health sector while managing new risks such as privacy, equity and implementation costs. It examines the following topics: improving service delivery models; empowering people to take an active role in their health and their care; improving public health; managing biomedical technologies; enabling better collaboration across borders; and improving health system governance and stewardship. It also examines how health workforces should be equipped to make the most of digital technology. The report contains findings from surveys of OECD countries and shares a range of examples that illustrate the potential benefits as well as challenges of the digital transformation in the health sector. Findings and recommendations are relevant for policymakers, health care providers, payers, industry as well as patients, citizens and civil society.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264508864
Category :
Languages : en
Pages : 298

View

Book Description
The objectives of this study are to describe experiences in price setting and how pricing has been used to attain better coverage, quality, financial protection, and health outcomes. It builds on newly commissioned case studies and lessons learned in calculating prices, negotiating with providers, and monitoring changes. Recognising that no single model is applicable to all settings, the study aimed to generate best practices and identify areas for future research, particularly in low- and middle-income settings. The report and the case studies were jointly developed by the OECD and the WHO Centre for Health Development in Kobe (Japan).

Author:
Publisher: World Health Organization
ISBN: 9240011870
Category : Business & Economics
Languages : en
Pages : 70

View

Book Description
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.